Lee, E.-J.; Na, W.; Kang, M.-K.; Kim, Y.-H.; Kim, D.-Y.; Oh, H.; Kim, S.-I.; Oh, S.-Y.; Park, S.; Park, K.;
et al. Hydroxycoumarin Scopoletin Inhibits Bone Loss through Enhancing Induction of Bone Turnover Markers in a Mouse Model of Type 2 Diabetes. Biomedicines 2021, 9, 648.
https://doi.org/10.3390/biomedicines9060648
AMA Style
Lee E-J, Na W, Kang M-K, Kim Y-H, Kim D-Y, Oh H, Kim S-I, Oh S-Y, Park S, Park K,
et al. Hydroxycoumarin Scopoletin Inhibits Bone Loss through Enhancing Induction of Bone Turnover Markers in a Mouse Model of Type 2 Diabetes. Biomedicines. 2021; 9(6):648.
https://doi.org/10.3390/biomedicines9060648
Chicago/Turabian Style
Lee, Eun-Jung, Woojin Na, Min-Kyung Kang, Yun-Ho Kim, Dong-Yeon Kim, Hyeongjoo Oh, Soo-Il Kim, Su-Yeon Oh, Sohyun Park, Kyungho Park,
and et al. 2021. "Hydroxycoumarin Scopoletin Inhibits Bone Loss through Enhancing Induction of Bone Turnover Markers in a Mouse Model of Type 2 Diabetes" Biomedicines 9, no. 6: 648.
https://doi.org/10.3390/biomedicines9060648
APA Style
Lee, E.-J., Na, W., Kang, M.-K., Kim, Y.-H., Kim, D.-Y., Oh, H., Kim, S.-I., Oh, S.-Y., Park, S., Park, K., & Kang, Y.-H.
(2021). Hydroxycoumarin Scopoletin Inhibits Bone Loss through Enhancing Induction of Bone Turnover Markers in a Mouse Model of Type 2 Diabetes. Biomedicines, 9(6), 648.
https://doi.org/10.3390/biomedicines9060648
